268 related articles for article (PubMed ID: 10092545)
1. The immunotolerance role of HLA-G.
Rouas-Freiss N; Khalil-Daher I; Riteau B; Menier C; Paul P; Dausset J; Carosella ED
Semin Cancer Biol; 1999 Feb; 9(1):3-12. PubMed ID: 10092545
[TBL] [Abstract][Full Text] [Related]
2. HLA-G promotes immune tolerance.
Rouas-Freiss N; Paul P; Dausset J; Carosella ED
J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
[TBL] [Abstract][Full Text] [Related]
3. HLA-G expression: immune privilege for tumour cells?
Cabestre FA; Lefebvre S; Moreau P; Rouas-Friess N; Dausset J; Carosella ED; Paul P
Semin Cancer Biol; 1999 Feb; 9(1):27-36. PubMed ID: 10092548
[TBL] [Abstract][Full Text] [Related]
4. HLA-G inhibits the transendothelial migration of human NK cells.
Dorling A; Monk NJ; Lechler RI
Eur J Immunol; 2000 Feb; 30(2):586-93. PubMed ID: 10671215
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
6. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
7. [HLA-G: immunoregulatory molecule involved in allograft acceptance].
Creput C; Durrbach A; Charpentier B; Carosella ED; Rouas-Freiss N
Nephrologie; 2003; 24(8):451-6. PubMed ID: 14737978
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
10. HLA-G*0105N null allele encodes functional HLA-G isoforms.
Le Discorde M; Le Danff C; Moreau P; Rouas-Freiss N; Carosella ED
Biol Reprod; 2005 Aug; 73(2):280-8. PubMed ID: 15814900
[TBL] [Abstract][Full Text] [Related]
11. Inadequate tolerance induction may induce pre-eclampsia.
Saito S; Sakai M; Sasaki Y; Nakashima A; Shiozaki A
J Reprod Immunol; 2007 Dec; 76(1-2):30-9. PubMed ID: 17935792
[TBL] [Abstract][Full Text] [Related]
12. [Genetic polymorphisms, function and clinical effect of HLA-G].
Meng H; Hou Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):350-3. PubMed ID: 12170478
[TBL] [Abstract][Full Text] [Related]
13. [HLA-G: a non classical antigen of major histocompatibility complex].
Carosella E; Kirszenbaum M; Dausset J
C R Acad Sci III; 1995 Aug; 318(8):827-30. PubMed ID: 7583770
[No Abstract] [Full Text] [Related]
14. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
15. [HLA-G in organ transplantation].
Le Maoult J; Rouas-Freiss N; Le Discorde M; Moreau P; Carosella ED
Pathol Biol (Paris); 2004 Mar; 52(2):97-103. PubMed ID: 15001239
[TBL] [Abstract][Full Text] [Related]
16. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
17. HLA-G and immune tolerance in pregnancy.
Hunt JS; Petroff MG; McIntire RH; Ober C
FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
[TBL] [Abstract][Full Text] [Related]
18. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity.
Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S
Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285
[TBL] [Abstract][Full Text] [Related]
19. HLA-G and its KIR ligands in cancer--another enigma yet to be solved?
Urosevic M; Trojan A; Dummer R
J Pathol; 2002 Mar; 196(3):252-3. PubMed ID: 11857486
[TBL] [Abstract][Full Text] [Related]
20. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
